(Q38307616)

2 September 2017

1 reference

title

Advances in understanding the pathogenesis of systemic anaplastic large cell lymphomas (English)

1 reference

2 September 2017

3

Giorgio Inghirami

0 references

author name string

Michela Boi

1

1 reference

2 September 2017

Emanuele Zucca

2

1 reference

2 September 2017

Giorgio Inghirami

3

1 reference

2 September 2017

Francesco Bertoni

4

1 reference

2 September 2017

language of work or name

English

0 references

publication date

6 January 2015

1 reference

British Journal of Haematology

2 September 2017

published in

1 reference

2 September 2017

volume

168

1 reference

2 September 2017

issue

6

1 reference

2 September 2017

page(s)

771-783

1 reference

Breast implant-associated anaplastic large cell lymphoma: sensitivity, specificity, and findings of imaging studies in 44 patients

2 September 2017

cites work

1 reference

Phase I/II study of an anti-CD30 monoclonal antibody (MDX-060) in Hodgkin's lymphoma and anaplastic large-cell lymphoma.

21 January 2018

1 reference

The aggressive peripheral T-cell lymphomas: 2012 update on diagnosis, risk stratification, and management

21 January 2018

1 reference

Analysis of gene expression profile of TPM3-ALK positive anaplastic large cell lymphoma reveals overlapping and unique patterns with that of NPM-ALK positive anaplastic large cell lymphoma.

21 January 2018

1 reference

Genetic alterations in systemic nodal and extranodal non-cutaneous lymphomas derived from mature T cells and natural killer cells

21 January 2018

1 reference

PRDM1/BLIMP1 is commonly inactivated in anaplastic large T-cell lymphoma

21 January 2018

1 reference

Anti-apoptotic signaling of pleiotrophin through its receptor, anaplastic lymphoma kinase.

21 January 2018

1 reference

Single-drug vinblastine as salvage treatment for refractory or relapsed anaplastic large-cell lymphoma: a report from the French Society of Pediatric Oncology

21 January 2018

1 reference

The specificity of JAK3 kinase inhibitors

21 January 2018

1 reference

The anaplastic lymphoma kinase in the pathogenesis of cancer

21 January 2018

1 reference

The anaplastic lymphoma kinase is an effective oncoantigen for lymphoma vaccination

21 January 2018

1 reference

IL-6 switches the differentiation of monocytes from dendritic cells to macrophages

21 January 2018

1 reference

Monoallelic mutations of the perforin gene may represent a predisposing factor to childhood anaplastic large cell lymphoma.

21 January 2018

1 reference

ATIC-ALK: A novel variant ALK gene fusion in anaplastic large cell lymphoma resulting from the recurrent cryptic chromosomal inversion, inv(2)(p23q35).

21 January 2018

1 reference

Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor

21 January 2018

1 reference

STAT3 mutations identified in human hematologic neoplasms induce myeloid malignancies in a mouse bone marrow transplantation model.

21 January 2018

1 reference

MiR-29a down-regulation in ALK-positive anaplastic large cell lymphomas contributes to apoptosis blockade through MCL-1 overexpression

21 January 2018

1 reference

Recurrent translocations involving the IRF4 oncogene locus in peripheral T-cell lymphomas

21 January 2018

1 reference

PAX5-positive T-cell anaplastic large cell lymphomas associated with extra copies of the PAX5 gene locus

21 January 2018

1 reference

Discovery of recurrent t(6;7)(p25.3;q32.3) translocations in ALK-negative anaplastic large cell lymphomas by massively parallel genomic sequencing

21 January 2018

1 reference

Crizotinib in the treatment of non-small-cell lung cancer.

21 January 2018

1 reference

A Phase II study of SGN-30 (anti-CD30 mAb) in Hodgkin lymphoma or systemic anaplastic large cell lymphoma.

21 January 2018

1 reference

Identification of NVP-TAE684, a potent, selective, and efficacious inhibitor of NPM-ALK.

21 January 2018

1 reference

The ALK inhibitor ASP3026 eradicates NPM-ALK⁺ T-cell anaplastic large-cell lymphoma in vitro and in a systemic xenograft lymphoma model

21 January 2018

1 reference

Restoration of shp1 expression by 5-AZA-2'-deoxycytidine is associated with downregulation of JAK3/STAT3 signaling in ALK-positive anaplastic large cell lymphoma

21 January 2018

1 reference

Molecular signatures to improve diagnosis in peripheral T-cell lymphoma and prognostication in angioimmunoblastic T-cell lymphoma

21 January 2018

1 reference

Gene expression signatures delineate biological and prognostic subgroups in peripheral T-cell lymphoma

21 January 2018

1 reference

Identification of FOXO3 and PRDM1 as tumor-suppressor gene candidates in NK-cell neoplasms by genomic and functional analyses

21 January 2018

1 reference

PRDM1 is a tumor suppressor gene in natural killer cell malignancies

21 January 2018

1 reference

Non-muscle myosin heavy chain (MYH9): a new partner fused to ALK in anaplastic large cell lymphoma

21 January 2018

1 reference

Gene-expression profiling of systemic anaplastic large-cell lymphoma reveals differences based on ALK status and two distinct morphologic ALK+ subtypes

21 January 2018

1 reference

Vinblastine in children and adolescents with high-risk anaplastic large-cell lymphoma: results of the randomized ALCL99-vinblastine trial.

21 January 2018

1 reference

Survival signals and targets for therapy in breast implant-associated ALK--anaplastic large cell lymphoma.

21 January 2018

1 reference

Development of anaplastic lymphoma kinase (ALK) small-molecule inhibitors for cancer therapy

21 January 2018

1 reference

The Akt/PKB family of protein kinases: a review of small molecule inhibitors and progress towards target validation: a 2009 update

21 January 2018

1 reference

MicroRNA expression profiling identifies molecular signatures associated with anaplastic large cell lymphoma

21 January 2018

1 reference

Differential induction of glioblastoma migration and growth by two forms of pleiotrophin

21 January 2018

1 reference

ALK-negative anaplastic large cell lymphoma with extensive peripheral blood and bone marrow involvements manifested as "leukemic phase".

21 January 2018

1 reference

The NPM-ALK and the ATIC-ALK fusion genes can be detected in non-neoplastic cells

21 January 2018

1 reference

BLIMP1 is a tumor suppressor gene frequently disrupted in activated B cell-like diffuse large B cell lymphoma

21 January 2018

1 reference

ALK as a paradigm of oncogenic promiscuity: different mechanisms of activation and different fusion partners drive tumors of different lineages

21 January 2018

1 reference

Identification of putative pathogenic microRNA and its downstream targets in anaplastic lymphoma kinase-negative anaplastic large cell lymphoma.

21 January 2018

1 reference

Identification of differential and functionally active miRNAs in both anaplastic lymphoma kinase (ALK)+ and ALK- anaplastic large-cell lymphoma

21 January 2018

1 reference

Novel therapeutic options in anaplastic large cell lymphoma: molecular targets and immunological tools

21 January 2018

1 reference

Novel 2,3,4,5-tetrahydro-benzo[d]azepine derivatives of 2,4-diaminopyrimidine, selective and orally bioavailable ALK inhibitors with antitumor efficacy in ALCL mouse models.

21 January 2018

1 reference

Breast implant-associated anaplastic large-cell lymphoma: long-term follow-up of 60 patients.

21 January 2018

1 reference

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

Anaplastic lymphoma kinase is a dependence receptor whose proapoptotic functions are activated by caspase cleavage.

21 January 2018

1 reference

Hsp90 molecular chaperone inhibitors: are we there yet?

21 January 2018

1 reference

STAT3 mutations are present in aggressive B-cell lymphomas including a subset of diffuse large B-cell lymphomas with CD30 expression

21 January 2018

1 reference

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

Fusion of the SEC31L1 and ALK genes in an inflammatory myofibroblastic tumor

21 January 2018

1 reference

ALK-negative anaplastic large cell lymphoma is a genetically heterogeneous disease with widely disparate clinical outcomes.

21 January 2018

1 reference

Inactivation of the PRDM1/BLIMP1 gene in diffuse large B cell lymphoma

21 January 2018

1 reference

ALK as a novel lymphoma-associated tumor antigen: identification of 2 HLA-A2.1-restricted CD8+ T-cell epitopes

21 January 2018

1 reference

Human Immunodeficiency Virus-associated anaplastic large cell lymphoma

21 January 2018

1 reference

Breast Implant-Associated Anaplastic Large Cell Lymphoma: What We Can Do.

21 January 2018

1 reference

GSK1838705A inhibits the insulin-like growth factor-1 receptor and anaplastic lymphoma kinase and shows antitumor activity in experimental models of human cancers

21 January 2018

1 reference

Genomic profiling reveals different genetic aberrations in systemic ALK-positive and ALK-negative anaplastic large cell lymphomas.

21 January 2018

1 reference

ALK- anaplastic large-cell lymphoma is clinically and immunophenotypically different from both ALK+ ALCL and peripheral T-cell lymphoma, not otherwise specified: report from the International Peripheral T-Cell Lymphoma Project

21 January 2018

1 reference

Treatment and prognosis of mature T-cell and NK-cell lymphoma: an analysis of patients with T-cell lymphoma treated in studies of the German High-Grade Non-Hodgkin Lymphoma Study Group

21 January 2018

1 reference

Farnesyltransferase and geranylgeranyltransferase I inhibitors and cancer therapy: lessons from mechanism and bench-to-bedside translational studies

21 January 2018

1 reference

Selective chemical probe inhibitor of Stat3, identified through structure-based virtual screening, induces antitumor activity

21 January 2018

1 reference

Anaplastic large cell lymphoma: a clinicopathologic analysis

21 January 2018

1 reference

Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer

21 January 2018

1 reference

STAT3-mediated activation of microRNA cluster 17~92 promotes proliferation and survival of ALK-positive anaplastic large cell lymphoma

21 January 2018

1 reference

Identification of anaplastic lymphoma kinase as a receptor for the growth factor pleiotrophin

21 January 2018

1 reference

Midkine binds to anaplastic lymphoma kinase (ALK) and acts as a growth factor for different cell types

21 January 2018

1 reference

KIF5B-ALK, a novel fusion oncokinase identified by an immunohistochemistry-based diagnostic system for ALK-positive lung cancer

21 January 2018

1 reference

Differential gene expression in anaplastic lymphoma kinase-positive and anaplastic lymphoma kinase-negative anaplastic large cell lymphomas

21 January 2018

1 reference

Molecular characterization of a new ALK translocation involving moesin (MSN-ALK) in anaplastic large cell lymphoma

21 January 2018

1 reference

ABT-263: a potent and orally bioavailable Bcl-2 family inhibitor

21 January 2018

1 reference

Genome-wide analysis reveals recurrent structural abnormalities of TP63 and other p53-related genes in peripheral T-cell lymphomas.

21 January 2018

1 reference

The battle against ALK resistance: successes and setbacks.

21 January 2018

1 reference

Anaplastic lymphoma kinase: role in cancer pathogenesis and small-molecule inhibitor development for therapy

21 January 2018

1 reference

Brentuximab vedotin (SGN-35) for relapsed CD30-positive lymphomas

21 January 2018

1 reference

Activating mutations in ALK kinase domain confer resistance to structurally unrelated ALK inhibitors in NPM-ALK-positive anaplastic large-cell lymphoma

21 January 2018

1 reference

Genomic profiling of peripheral T-cell lymphoma, unspecified, and anaplastic large T-cell lymphoma delineates novel recurrent chromosomal alterations

21 January 2018

1 reference

An orally available small-molecule inhibitor of c-Met, PF-2341066, exhibits cytoreductive antitumor efficacy through antiproliferative and antiangiogenic mechanisms

21 January 2018

1 reference

Production of a monoclonal antibody specific for Hodgkin and Sternberg–Reed cells of Hodgkin's disease and a subset of normal lymphoid cells

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1111/BJH.13265

1 reference

2 September 2017

1 reference